Popular Antibiotic May Be Responsible For Sudden Cardiac Death

Lawrence LeBlond for RedOrbit.com Azithromycin, a common antibiotic used for treatment of bronchitis, pneumonia, and sexually transmitted diseases (STDs), appears to also boost the risk of sudden cardiac death when compared with no antibiotic treatment, according to a US study on Wednesday. Azithromycin has been available worldwide since the 1980s, but the new study, published in the New England ...

Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant ...

NEW YORK, May 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Antibacterials Market to 2017 - Innovative Anti-Infectives that Target ...

Acupuncture may help some people with COPD: study

NEW YORK (Reuters Health) - Three months of acupuncture improved breathing problems in people with chronic lung disease, in a new study from Japan. According to one researcher, the benefits seen with the alternative treatment were on par with, or better than, what's been shown for conventional drugs and exercises used to treat the disease. But the study was small, he added, and more research ...

Common antibiotic boosts death risk: Study

WASHINGTON, May 19 – A popular antibiotic used for treating bronchitis, pneumonia, ear infections and sexually transmitted diseases may boost the risk of death, a US study said on Wednesday. Azithromycin has been on the worldwide market since the 1980s, but the study in the New England Journal of Medicine is the first to document serious heart ...

Results of Phase II Study of Boehringer Ingelheim's Investigational Bronchodilator for COPD Presented at 2012 ATS ...

SAN FRANCISCO, May 21, 2012 /PRNewswire/ -- Data from a Phase II trial of olodaterol presented today at the 2012 Annual International Conference of the American Thoracic Society (ATS 2012) compared the ...